Stay updated on Belantamab vs Bortezomib in MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page
- CheckyesterdayChange DetectedA new revision (v3.6.3) was added, replacing the previous revision (v3.6.2), indicating a small platform update rather than a change to the study details.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision: v3.6.2 is now shown on the page, and the items 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and 'Revision: v3.6.0' were removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRecruitment status updated to no longer recruit participants, and the locations section expanded to 122 sites with new entries in China, Brazil, and New Zealand. The page also added guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and included the sponsor's data-sharing policy.SummaryDifference0.9%

- Check30 days agoChange DetectedThe page now lists Multiple myeloma and MedlinePlus Genetics as related topics. The revision/version tag was updated from v3.5.4 to v3.5.5 to reflect the latest page revision.SummaryDifference0.1%

- Check37 days agoChange DetectedThe Related Topics section no longer lists 'Multiple myeloma' and 'MedlinePlus Genetics' on the DREAMM-8 study page. This reduces quick access to disease-focused and genetics resources but does not alter the study's primary content or data.SummaryDifference0.1%

- Check44 days agoChange DetectedRelated topics section now includes 'Multiple myeloma' and a link to 'MedlinePlus Genetics'. This addition places the study in the disease context and improves navigation to genetics-related information.SummaryDifference0.1%

Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.